These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13922446)

  • 1. [New antiphlogistic drugs: G-27202].
    TREZZINI C
    Clin Ter; 1962 Jul; 23():57-63. PubMed ID: 13922446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the antiphlogistic agent G 27202 (Tanderil)].
    von RECHENBERG H; HERRMANN B
    Schweiz Med Wochenschr; 1961 Apr; 91():403-5. PubMed ID: 13740155
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with the antiphlogistic G 27202 in anti-smallpox vaccination of children].
    ZAULI NALDI G
    Clin Pediatr (Bologna); 1961 Dec; 43():1013-21. PubMed ID: 14009920
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiphlogistic therapy of inflammatory processes of the female pelvis with a new pyrazole derivative].
    MASSANO A; CREMONA GF
    Minerva Ginecol; 1962 Feb; 14():229-33. PubMed ID: 14470887
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the use and antiphlogistic therapeutic effectiveness of a metabolite of phenylbutazone in some disease processes of otorhinolaryngoiatric interest].
    PAROLARI P
    Otorinolaringol Ital; 1961 Dec; 30():462-6. PubMed ID: 14484015
    [No Abstract]   [Full Text] [Related]  

  • 6. A study on the use of phenylbutazone and oxyphenbutazone in obstetrics and gynecology.
    RADMAN HM
    Sinai Hosp J (Balt); 1960; 9():225-30. PubMed ID: 13738978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione].
    LENFELD J; KROUTIL M; BOCEK M; CTVRTNIK J; MAYER J
    Arzneimittelforschung; 1961 Apr; 11():427-9. PubMed ID: 13760809
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of a new antiphlogistic agent on capillary permeability].
    MASTROJENI D; CAMBRIA S
    Gazz Int Med Chir; 1962 Jul; 66():1591-9. PubMed ID: 14470998
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiphlogistic effects of new antirheumatic drugs. Clinical observation].
    CARNEIRO RA
    Hospital (Rio J); 1961 Dec; 60():965-73. PubMed ID: 13876705
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical evaluation of a new anti-inflammatory agent; a preliminary report.
    CONNELL JF; ROUSSELOT LM
    Am J Surg; 1959 Jul; 98(1):31-3. PubMed ID: 13661510
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with oxyphenbutazone in the treatment of inflammation and edema.
    MILLER JM; GINSBERG M; ARCE SQ; BOGOSIAN A; SMITH LB
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():109-14. PubMed ID: 14422539
    [No Abstract]   [Full Text] [Related]  

  • 12. [The binding of the antiphlogistic agent phydroxyphenylbutazone to serum proteins].
    WUNDERLY C
    Arzneimittelforschung; 1960 Nov; 10():910-1. PubMed ID: 13786916
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of the anti-inflammatory effects of a metabolite of butazolidine, G 27202].
    RAVINA A
    Presse Med (1893); 1962 Feb; 70():369-71. PubMed ID: 14490663
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the clinical trial of the new antiphlogistic drug G 27,202 in tonsillectomy].
    CANCURA W
    Ther Umsch; 1960 Sep; 17():314-5. PubMed ID: 13690373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with the antiphlogistic drug G 27,202].
    BARCZYK W; ROETH G
    Praxis; 1960 Jun; 49():589-91. PubMed ID: 13796682
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxyphenbutazone in the management of acute inflammatory disorders.
    BILLOW BW; PALEY SS; CAREY RM; LOWEN H; MIHALY JM; THOMPSON EA; ROWE C
    J New Drugs; 1962; 2():115-9. PubMed ID: 13869208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical results on the application of the new antiphlogistic preparation, G-27202 (Tanderil) in ocular diseases].
    CHINAGLIA V; CREPALDI A
    Ann Ottalmol Clin Ocul; 1961 Oct; 87():529-39. PubMed ID: 13878997
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with a new antiphlogistic drug (Tanderil) in ophthalmology].
    PESTALOZZI D
    Praxis; 1961 Oct; 50():1046-8. PubMed ID: 14485691
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiphlogistic action of phenylbutazone in normal and adrenalectomized rats of different ages relation to the 5-hydroxytryptamine blood concentration.
    Kohút A; Nicák A
    Physiol Bohemoslov; 1975; 24(4):369-75. PubMed ID: 125891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis and therapy of frequent sport injuries and sport wounds with a new antiphlogistic].
    KOCHNER G
    Med Klin; 1961 Dec; 56():2094-6. PubMed ID: 14457597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.